Abstract
It is now recognised that the spectrum of antiphospholipid (aPL)-mediated syndromes includes end-organ injury due to microangiopathic manifestations. In the central nervous system (CNS), the clinical and radiographic appearance of microangiopathic lesions can be notoriously difficult to distinguish from multiple sclerosis (MS). A patient is presented who developed white-matter lesions in the brain and spinal-cord, shortly after receiving toxic doses of radiation for an arterio-venous malformation. The institution of interferon therapy for presumptive MS not only led to worsening neurologic deficits, but triggered a cutaneous syndrome with pleomorphic stigmata of microvascular injury (livedo reticularis rash, splinter haemorrhages). Subsequent workup revealed persistently elevated high-titer antiphospholipid of multiple isotypes. Treatment with corticosteroids and immunosuppressant therapy afforded improvement in locomotor function. We hypothesise that radiation injury and treatment with interferon-therapy constituted iatrogenic "hits" of endothelial injury, and potentiated aPL-mediated microangiopathic disease affecting the CNS and the skin.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 411-415 |
| Number of pages | 5 |
| Journal | Clinical and experimental rheumatology |
| Volume | 28 |
| Issue number | 3 |
| State | Published - Dec 1 2010 |
Keywords
- Antiphospholipid antibody syndrome
- Neuropsychiatric disease
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology
Fingerprint
Dive into the research topics of 'Additional triggers of endothelial dysfunction modulate antiphospholipid-mediated microangiopathy in a central nervous system-cutaneous syndrome'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS